Featured Research

from universities, journals, and other organizations

Hybrid revascularization effective for left main coronary blockages

Date:
March 15, 2010
Source:
Emory University
Summary:
Hybrid revascularization is a combination of coronary artery bypass surgery and percutaneous coronary intervention.

The left main coronary artery provides most of the blood to the heart, and current guidelines call for patients with blockages in this artery to undergo bypass surgery.

Hybrid revascularization is a combination of coronary artery bypass surgery and percutaneous coronary intervention (PCI). Emory physicians have been performing these procedures "off-pump" in a minimally invasive fashion, without breaking open the chest. This technique is also known as "endo-ACAB" (endoscopic atraumatic coronary artery bypass).

Syed Tanveer Rab, MD, assistant professor of medicine (cardiology), Emory University School of Medicine, will report on outcomes from 21 Emory patients with blockages in the left main coronary artery treated using hybrid revascularization.

The presentation took place at the American College of Cardiology meeting in Atlanta on March 15.

Rab describes the Emory approach as a "best of both worlds strategy": minimally invasive off-pump left internal mammary artery (LIMA) graft, plus a stent placed via ultrasound from the left main to the left circumflex artery.

For these patients, the average ICU stay was 1.1 0.4 days. Fifteen patients had hybrid surgery and PCI in the same hospitalization and the rest had the two procedures a few days apart. All but one patient received a drug eluting stent. Two had re-exploration with blood transfusion. No major adverse cardiac or cerebrovascular events were reported in the hospital or after 30 days.

The authors conclude: "Hybrid revascularization for left main coronary artery stenosis appears to be a safe and feasible procedure in selected patients and may preserve the survival advantage imparted by the left internal mammary artery graft to the left anterior descending artery. A multicenter trial to assess intermediate and long term outcomes of this form of hybrid revascularization is warranted."

Emory, Columbia University and Albert Einstein College of Medicine recently received a $1 million "Challenge" grant from the National Heart, Lung and Blood Institute to plan a large-scale clinical trial of hybrid revascularization.

Emory's investigator on this grant is John Puskas, MD, professor of surgery and associate chief, division of cardiothoracic surgery at Emory University School of Medicine.


Story Source:

The above story is based on materials provided by Emory University. Note: Materials may be edited for content and length.


Journal Reference:

  1. T.A. Vassiliades et al. Clinical Outcomes After Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass: A Prospective Evaluation. Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery, 2009; 4 (6): 299 DOI: 10.1097/IMI.0b013e3181bbfa96

Cite This Page:

Emory University. "Hybrid revascularization effective for left main coronary blockages." ScienceDaily. ScienceDaily, 15 March 2010. <www.sciencedaily.com/releases/2010/03/100315161923.htm>.
Emory University. (2010, March 15). Hybrid revascularization effective for left main coronary blockages. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2010/03/100315161923.htm
Emory University. "Hybrid revascularization effective for left main coronary blockages." ScienceDaily. www.sciencedaily.com/releases/2010/03/100315161923.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins